Polycystic ovary syndrome (PCOS), hyperandrogenism and overweight/obesity, independently and interactively, increase the risk of metabolic syndrome

Meri‐Maija Ollila; S. Keinänen-Kiukaanniemi; Terhi Piltonen; Jari Jokelainen; Paul M Ridker; Juha S. Tapanainen; Stephen Franks; Laure Morin‐Papunen

Related publications

Article2017

Hyperandrogenism and overweight/obesity, independently and interactively, increase the risk of metabolic syndrome and type 2 diabetes in women - a Prospective, Population-based Cohort Study

Meri‐Maija Ollila, Kari Kaikkonen, Sirkka Keinänen‐Kiukaanniemi, Katri Puukka, Aimo Ruokonen, Paul M Ridker, Juha S. Tapanainen, Steve Franks, Terhi Piltonen, Laure Morin‐Papunen

Article1998

Polycystic ovary syndrome and hyperandrogenism as a risk factor for cardiovascular disease.

Hannu Martikainen, Aimo Ruokonen, Hartikainen Al, Paul M Ridker

Article2013

CYP21A2 Mutations in Women with Polycystic Ovary Syndrome (PCOS)

Nikolaos Settas, Maria Dracopoulou-Vabouli, Antonia Dastamani, Ilias Katsikis, George Chrousos, Dimitrios Panidis, Catherine Dacou‐Voutetakis

Article2010

Hyperandrogenism in Women with Polycystic Ovary Syndrome Persists after Menopause

Marios C Markopoulos, Demetrios Rizos, George Valsamakis, Efthimios Deligeoroglou, Odysseas Grigoriou, George Chrousos, George Creatsas, George Mastorakos

Article2017

Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity

Alexessander Couto Alves, B. Valcarcel, Ville‐Petteri Mäkinen, Laure Morin‐Papunen, Sylvain Sebért, Antti J. Kangas, Pasi Soininen, Subhradip Das, Maria De Iorio, Lachlan Coin, Mika Ala‐Korpela, Paul M Ridker, S. Franks